Reuters logo
BRIEF-Novozymes says buys Canadian enzyme business from Iogen
January 31, 2013 / 8:06 AM / in 5 years

BRIEF-Novozymes says buys Canadian enzyme business from Iogen

COPENHAGEN, Jan 31 (Reuters) - Denmark’s Novozymes A/S said on Thursday: * Acquires enzyme business from Canadian Iogen Corporation * Acquires Iogen Bio-Products, the industrial enzyme business of

Ottawa-based Iogen Corporation for CAD 67.5 million * Sees potential earn-out payments of up to CAD 12.5 million * Acquisition is expected to have a positive impact on Novozymes’ sales

growth in 2013 of around 0.5 percentage point depending on when the

acquisition is closed

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below